Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants.

Saved in:
Bibliographic Details
Title: Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants.
Authors: Burton S; Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Spicer LM; Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Charles TP; Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Gangadhara S; Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Reddy PBJ; Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Styles TM; Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Velu V; Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Kasturi SP; Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Legere T; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Hunter E; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.; Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Pulendran B; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.; Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA., Amara R; Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.; Department of Microbiology and Immunology, Emory University, Atlanta, Georgia, USA., Hraber P; Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico, USA., Derdeyn CA; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA cderdey@emory.edu.; Emory Vaccine Center, Emory University, Atlanta, Georgia, USA.; Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Source: Journal of virology [J Virol] 2019 Mar 21; Vol. 93 (7). Date of Electronic Publication: 2019 Mar 21 (Print Publication: 2019).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1098-5514 (Electronic) Linking ISSN: 0022538X NLM ISO Abbreviation: J Virol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-5514
DOI:10.1128/JVI.01846-18